Perfil
Koos van Haasteren is currently the Chairman-Supervisory Board at Chemelot Campus BV.
Previously, he worked as the Chief Executive Officer at Alloksys Life Sciences BV.
Cargos activos de Koos van Haasteren
Empresas | Cargo | Inicio |
---|---|---|
Chemelot Campus BV
Chemelot Campus BV Real Estate DevelopmentFinance Chemelot Campus BV operates a science and innovation park. The firm offers entrepreneurs, scientists, and students facilities to support development and growth. Its campus houses educational and research institutes. The company was founded in 2002 and is headquartered in Sittard-Geleen, the Netherlands. | Presidente | - |
Antiguos cargos conocidos de Koos van Haasteren.
Empresas | Cargo | Fin |
---|---|---|
Alloksys Life Sciences BV
Alloksys Life Sciences BV Miscellaneous Commercial ServicesCommercial Services Alloksys Life Sciences BV provides therapies services. It offers Phase 3 clinical trials leading to registration of RESCAP (RESCuing Alkaline Phosphatase) for the prevention and treatment of ischemic injury and inflammation mediated complications in cardiothoracic surgery (APPIRED III). The company was founded by Ruud Brands in 2005 and is headquartered in Wageningen, the Netherlands. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Chemelot Campus BV
Chemelot Campus BV Real Estate DevelopmentFinance Chemelot Campus BV operates a science and innovation park. The firm offers entrepreneurs, scientists, and students facilities to support development and growth. Its campus houses educational and research institutes. The company was founded in 2002 and is headquartered in Sittard-Geleen, the Netherlands. | Finance |
Alloksys Life Sciences BV
Alloksys Life Sciences BV Miscellaneous Commercial ServicesCommercial Services Alloksys Life Sciences BV provides therapies services. It offers Phase 3 clinical trials leading to registration of RESCAP (RESCuing Alkaline Phosphatase) for the prevention and treatment of ischemic injury and inflammation mediated complications in cardiothoracic surgery (APPIRED III). The company was founded by Ruud Brands in 2005 and is headquartered in Wageningen, the Netherlands. | Commercial Services |
- Bolsa de valores
- Insiders
- Koos van Haasteren